BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7683572)

  • 1. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
    Tan TM; Ting RC
    Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect on cancer cells of plasmids that express antisense RNA of human papillomavirus type 18.
    Steele C; Sacks PG; Adler-Storthz K; Shillitoe EJ
    Cancer Res; 1992 Sep; 52(17):4706-11. PubMed ID: 1324791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The inhibitory effect of antisense--RNA of papillomavirus type 16 E6E7 genes on malignant phenotypes of cervical carcinoma cell line].
    Ming L; Zhou L; Shang M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Mar; 12(1):54-7. PubMed ID: 12515173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells.
    Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF
    Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
    DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD
    Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antisense targeting to human papillomavirus 18 E6/E7 affects the proliferation and apoptosis of human cervical carcinoma: an in vitro experiment with HeLa cells].
    Sima N; Kong DB; Wang W; Lu YP; Wang SX; Ma D
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(23):1618-21. PubMed ID: 17803852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer.
    Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M
    Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines.
    Nakamura K; Hongo A; Kodama J; Miyagi Y; Yoshinouchi M; Kudo T
    Cancer Res; 2000 Feb; 60(3):760-5. PubMed ID: 10676665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic activity of oligonucleotides with polarity and anomeric center reversal.
    Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of human papillomavirus 16 DNA-positive mouse tumor by antisense RNA transcribed from U6 promoter.
    He Y; Huang L
    Cancer Res; 1997 Sep; 57(18):3993-9. PubMed ID: 9307284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical study on gene therapy of cervical carcinoma using adeno-associated virus vectors.
    Kunke D; Grimm D; Denger S; Kreuzer J; Delius H; Komitowski D; Kleinschmidt JA
    Cancer Gene Ther; 2000 May; 7(5):766-77. PubMed ID: 10830724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
    Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
    Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the p53-target gene GADD45 in HPV-positive cancer cells.
    Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F
    Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the development of ribozymes and antisense oligodeoxynucleotides as antiviral agents for human papillomaviruses.
    Alvarez-Salas LM; Benítez-Hess ML; DiPaolo JA
    Antivir Ther; 2003 Aug; 8(4):265-78. PubMed ID: 14518695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
    Tan TM; Gloss B; Bernard HU; Ting RC
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered growth and viral gene expression in human papillomavirus type 16-containing cancer cell lines treated with progesterone.
    Yuan F; Auborn K; James C
    Cancer Invest; 1999; 17(1):19-29. PubMed ID: 10999045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.